Lipoprotein(a) as a Risk Factor for Myocardial Infarction, Cardiovascular, and All-Cause Mortality in Patients with Type 2 Diabetes Mellitus

Jerneja Čuješ, Vojko Kanič, Petra Povalej Bržan, David Šuran · 2026

Read Lipoprotein(a) as a Risk Factor for Myocardial Infarction, Cardiovascular, and All-Cause Mortality in Patients with Type 2 Diabetes Mellitus by Jerneja Čuješ, Vojko Kanič, Petra Povalej Bržan, David Šuran (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13205150.txt.

Description

Jerneja Čuješ, Vojko Kanič, Petra Povalej Bržan, and David Šuran examine whether a blood fat called lipoprotein(a) predicts heart attacks and death in people with type 2 diabetes. Their paper appeared in 2026.

The team followed 2,967 patients who were treated in hospital between 2000 and 2018 and had no earlier heart attack. Over the follow-up, about one in eight patients had a heart attack. High levels of the blood fat meant a clearly higher risk of a first heart attack in women, but no clear link showed in men. Higher levels also tracked with more deaths from heart and vessel disease in the group as a whole. The authors say a simple blood test could help flag women with diabetes who face extra risk.

Catalog record

CREATORJerneja Čuješ, Vojko Kanič, Petra Povalej Bržan, David Šuran
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE26 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13205150

Browse the full library · About the Tower of Babel